Armstrong, C. W., McGregor, N. R., Sheedy, J. R., Buttfield, I., Butt, H. L., & Gooley, P. R. (2012). NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome. Clinica Chimica Acta, 413(19–20), 1525–1531. doi:10.1016/j.cca.2012.06.022.

Ax, S., Gregg, V. H., & Jones, D. (2001). Coping and illness cognitions: chronic fatigue syndrome. Clinical Psychology Review, 21(2), 161–182.

Booth, N. E., Myhill, S., & McLaren-Howard, J. (2012). Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). International Journal of Clinical and Experimental Medicine, 5(3), 208–220.

Brealey, D., & Singer, M. (2009). Hyperglycemia in critical illness: a review. Journal of Diabetes Science and Technology, 3(6), 1250–1260.

Buchwald, D., Ashley, R. L., Pearlman, T., Kith, P., & Komaroff, A. L. (1996). Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. Journal of Medical Virology, 50(1), 25–30. doi:10.1002/(SICI)1096-9071(199609)50:1<25:AID-JMV6>3.0.CO;2-V.

Cabrera, O., Jacques-Silva, M. C., Speier, S., Yang, S. N., Kohler, M., Fachado, A., et al. (2008). Glutamate is a positive autocrine signal for glucagon release. Cell Metabolism, 7(6), 545–554. doi:10.1016/j.cmet.2008.03.004.

Candy, B., Chalder, T., Cleare, A. J., Wessely, S., & Hotopf, M. (2004). A randomised controlled trial of a psycho-educational intervention to aid recovery in infectious mononucleosis. Journal of Psychosomatic Research, 57(1), 89–94. doi:10.1016/S0022-3999(03)00370-2.

Candy, B., Chalder, T., Cleare, A. J., Wessely, S., White, P. D., & Hotopf, M. (2002). Recovery from infectious mononucleosis: a case for more than symptomatic therapy? a systematic review. British Journal of General Practice, 52(483), 844–851.

Cao, M., George, T. J., Prima, V., Nelson, D., & Svetlov, S. (2013). Argininosuccinate synthase as a novel biomarker for inflammatory conditions. Biomarkers, 18(3), 242–249. doi:10.3109/1354750X.2013.773080.

Carruthers, B. M. (2007). Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works. Journal of Clinical Pathology, 60(2), 117–119. doi:10.1136/jcp.2006.042754.

Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., et al. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome, 11(1), 7–36.

Carruthers, B. M., van de Sande, M. I., De Meirleir, K. L., Klimas, N. G., Broderick, G., Mitchell, T., et al. (2011). Myalgic encephalomyelitis: International Consensus Criteria. Journal of Internal Medicine, 270(4), 327–338. doi:10.1111/j.1365-2796.2011.02428.x.

Christley, Y., Duffy, T., & Martin, C. R. (2012). A review of the definitional criteria for chronic fatigue syndrome. Journal of Evaluation in Clinical Practice, 18(1), 25–31. doi:10.1111/j.1365-2753.2010.01512.x.

Efron, B., & Tibshirani, R. (1993). An introduction to the bootstrap. New York: Chapman & Hall.

Fahien, L. A., & Macdonald, M. J. (2011). The complex mechanism of glutamate dehydrogenase in insulin secretion. Diabetes, 60(10), 2450–2454. doi:10.2337/db10-1150.

Filler, K., Lyon, D., Bennett, J., McCain, N., Elswick, R., Lukkahatai, N., et al. (2014). Association of mitochondrial dysfunction and fatigue: a review of the literature. BBA Clinical, 1, 12–23. doi:10.1016/j.bbacli.2014.04.001.

Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., & Komaroff, A. (1994). The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine, 121(12), 953–959.

Georgiades, E., Behan, W. M. H., Kilduff, L. P., Hadjicharalambous, M., Mackie, E. E., Wilson, J., et al. (2003). Chronic fatigue syndrome: new evidence for a central fatigue disorder. Clinical Science, 105(2), 213–218.

Holmes, G. P., Kaplan, J. E., Gantz, N. M., Komaroff, A. L., Schonberger, L. B., Straus, S. E., et al. (1988). Chronic fatigue syndrome: a working case definition. Annals of Internal Medicine, 108(3), 387–389.

Husson, A., Brasse-Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003). Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. European Journal of Biochemistry, 270(9), 1887–1899.

Jason, L. A., Richman, J. A., Rademaker, A. W., Jordan, K. M., Plioplys, A. V., Taylor, R. R., et al. (1999). A community-based study of chronic fatigue syndrome. Archives of Internal Medicine, 159(18), 2129–2137.

Johnson, S. K., DeLuca, J., & Natelson, B. H. (1999). Chronic fatigue syndrome: reviewing the research findings. Annals of Behavioral Medicine, 21(3), 258–271.

Jones, M. G., Cooper, E., Amjad, S., Goodwin, C. S., Barron, J. L., & Chalmers, R. A. (2005). Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. Clinica Chimica Acta, 361(1–2), 150–158. doi:10.1016/j.cccn.2005.05.023.

Kennedy, G., Spence, V. A., McLaren, M., Hill, A., Underwood, C., & Belch, J. J. (2005). Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biology and Medicine, 39(5), 584–589. doi:10.1016/j.freeradbiomed.2005.04.020.

Maes, M. (2009). Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Current Opinion in Psychiatry, 22(1), 75–83.

McGregor, N. R., Dunstan, R. H., Zerbes, M., Butt, H. L., Roberts, T. K., & Klineberg, I. J. (1996). Preliminary determination of a molecular basis to chronic fatigue syndrome. Biochemical and Molecular Medicine, 57(2), 73–80.

Meeus, M., Nijs, J., Hermans, L., Goubert, D., & Calders, P. (2013). The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets? Expert Opinion on Therapeutic Targets, 17(9), 1081–1089. doi:10.1517/14728222.2013.818657.

Meldrum, B. S. (2000). Glutamate as a neurotransmitter in the brain: review of physiology and pathology. Journal of Nutrition, 130(4S Suppl), 1007S–1015S.

Mikami, T., Kita, K., Tomita, S., Qu, G. J., Tasaki, Y., & Ito, A. (2000). Is allantoin in serum and urine a useful indicator of exercise-induced oxidative stress in humans? Free Radical Research, 32(3), 235–244.

Maes, M., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2011). Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Medical Science Monitor, 17(4), SC11–SC15.

Morris, G., & Maes, M. (2014a). Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metabolic Brain Disease, 29(1), 19–36. doi:10.1007/s11011-013-9435-x.

Morris, G., & Maes, M. (2014b). Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (me)/chronic fatigue syndrome (cfs). Current Neuropharmacology, 12(2), 168–185. doi:10.2174/1570159X11666131120224653.

Niblett, S. H., King, K. E., Dunstan, R. H., Clifton-Bligh, P., Hoskin, L. A., Roberts, T. K., et al. (2007). Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome. Experimental Biology and Medicine (Maywood), 232(8), 1041–1049. doi:10.3181/0702-RM-44.

Ortega-Hernandez, O. D., & Shoenfeld, Y. (2009). Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence? Annals of the New York Academy of Sciences, 1173, 600–609. doi:10.1111/j.1749-6632.2009.04799.x.

Robinson, L. E., & van Soeren, M. H. (2004). Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clinical Issues, 15(1), 45–62.

Serkova, N., Fuller, T. F., Klawitter, J., Freise, C. E., & Niemann, C. U. (2005). 1H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney International, 67(3), 1142–1151. doi:10.1111/j.1523-1755.2005.00181.x.

Sheedy, J. R., Ebeling, P. R., Gooley, P. R., & McConville, M. J. (2010). A sample preparation protocol for 1H nuclear magnetic resonance studies of water-soluble metabolites in blood and urine. Analytical Biochemistry, 398(2), 263–265. doi:10.1016/j.ab.2009.11.027.

Shungu, D. C., Weiduschat, N., Murrough, J. W., Mao, X., Pillemer, S., Dyke, J. P., et al. (2012). Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR in Biomedicine, 25(9), 1073–1087. doi:10.1002/nbm.2772.

Smits, B., van den Heuvel, L., Knoop, H., Kusters, B., Janssen, A., Borm, G., et al. (2011). Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion, 11(5), 735–738. doi:10.1016/j.mito.2011.05.005.

Snell, C. R., Stevens, S. R., Davenport, T. E., & Van Ness, J. M. (2013). Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome. Physical Therapy, 93(11), 1484–1492. doi:10.2522/ptj.20110368.

Suarez, A., Guillamo, E., Roig, T., Blazquez, A., Alegre, J., Bermudez, J., et al. (2010). Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study. Journal of Womens Health, 19(6), 1073–1077. doi:10.1089/jwh.2008.1255.

White, A. T., Light, A. R., Hughen, R. W., Bateman, L., Martins, T. B., Hill, H. R., et al. (2010). Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology, 47(4), 615–624. doi:10.1111/j.1469-8986.2010.00978.x.

White, A. T., Light, A. R., Hughen, R. W., Vanhaitsma, T. A., & Light, K. C. (2012). Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosomatic Medicine, 74(1), 46–54. doi:10.1097/PSY.0b013e31824152ed.

Xiu, F., Stanojcic, M., Diao, L., & Jeschke, M. G. (2014). Stress hyperglycemia, insulin treatment, and innate immune cells. International Journal of Endocrinology, 2014, 486403. doi:10.1155/2014/486403.